semaglutide and kidney failure Cardio-kidney-metabolic protective effects of across the spectrum of chronic disease Semaglutide in Diabetic Kidney Disease:

Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Exhibit 03 Strategic routes to GLP-1 category leadership Three routes to market, mapped against speed of deployment and depth of scientific differentiation

Phase III Clinical Research Trials Once enough data is collected from Phase II trials the drug will be approved to proceed into Phase III

Expertise in Weight Loss Programmes near me Around Miami, youll find many weight loss programs, but few can match our level of expertise in GLP-1 receptor agonist therapies, including Semaglutide and Tirzepatide

Better U Inc All rights reserved

And an interim analysis of a phase II Study of the glutaminase inhibitor CB-839 in combination with Azacitidine in advanced myelodysplastic syndrome (MDS) showed CB-839 at a dose of 600 mg BID orally continuously daily is safe and well tolerated in combination with azacitidine in patients with advanced MDS with an acceptable safety profile [92]